InterCure Ltd. (INCR)
5.62
-0.16
(-2.77%)
USD |
NASDAQ |
Aug 31, 15:22
InterCure Net Income (Quarterly)
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 1.020M |
| March 31, 2023 | 0.026M |
| December 31, 2022 | 1.509M |
| September 30, 2022 | 2.443M |
| June 30, 2022 | 4.620M |
| March 31, 2022 | 4.596M |
| December 31, 2021 | -0.9638M |
| September 30, 2021 | 0.167M |
| June 30, 2021 | 1.820M |
| March 31, 2021 | 0.9944M |
| December 31, 2020 | 3.069M |
| September 30, 2020 | 0.5616M |
| June 30, 2020 | -0.2786M |
| March 31, 2020 | -13.50M |
| December 31, 2016 | -0.056M |
| September 30, 2016 | 0.052M |
| June 30, 2016 | -0.234M |
| March 31, 2016 | 0.307M |
| December 31, 2015 | -0.231M |
| September 30, 2015 | -0.23M |
| June 30, 2015 | 0.045M |
| Date | Value |
|---|---|
| March 31, 2015 | -0.065M |
| December 31, 2014 | -0.114M |
| September 30, 2014 | -0.39M |
| June 30, 2014 | -0.317M |
| March 31, 2014 | -0.153M |
| December 31, 2013 | -0.479M |
| September 30, 2013 | -0.638M |
| June 30, 2013 | -0.42M |
| March 31, 2013 | -0.36M |
| December 31, 2012 | -0.369M |
| September 30, 2012 | 12.99M |
| June 30, 2012 | -0.095M |
| March 31, 2012 | -0.894M |
| December 31, 2011 | -0.001M |
| September 30, 2011 | 0.17M |
| June 30, 2011 | -1.002M |
| March 31, 2011 | -0.954M |
| December 31, 2010 | -1.101M |
| September 30, 2010 | -1.019M |
| June 30, 2010 | -0.764M |
| March 31, 2010 | -0.657M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IM Cannabis Corp. | -3.168M |
| Teva Pharmaceutical Industries Ltd. | -585.89M |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -7.392M |
| Purple Biotech Ltd. | 0.4486M |
Net Income (Quarterly) Related Metrics
| Enterprise Value | 80.75M |
| Earnings Yield | -17.79% |
| Normalized Earnings Yield | -17.11 |